If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
Subscribe To Our Newsletter & Stay Updated
